In conclusion, mp-MRI could be currently considered as the most reliable imaging biomarker to detect local PCa recurrence in patients with BF after RP or definitive RT; the major advantage could be achieved in presence of low rising PSA level, in order to perform an early and relevant treatment. The gene discussed is KLK3; the disease is posterior cortical atrophy.